LICENSE & BUSINESS OPPORTUNITIES

 CATARACT SURGERY

The Cefuroxime Application System is CIS Pharma’s patented drug/device combination for preparation and injection of cefuroxime intracameral antibiotic to prevent Endophthalmitis ›

Marketed in Europe we offer

  • License to drug/device patent
  • Dossier for approval of cefuroxime
  • Supply of drug and proprietary devices
CONTACT

CONTACT LENS CARE

CIS Pharma has developed bio-inspired contact lens care products with superior disinfecting power, an innovative comfort-agent and a physiological mix of minerals for protection and regeneration of corneal cells ›

Marketed in Switzerland we offer

  • License to patented product
  • Develop client-specific product based on patented platform
CONTACT

ADC DRUG CARRIER

CIS Pharma develops novel antibody-drug- conjugates based on our proprietary polymer carrier platform. Our polymers serve as carriers that are loaded with cytotoxic drugs, radioisotopes and other cancer treatments ›

We offer to develop ADCs for partners with

  • Antibodies, fragments, nanobodies
  • Checkpoint inhibitors, immunotherapies
  • Cytotoxins, radioisotopes
  • Therapeutic oligonucleotides
  • Linker and conjugation technologies
CONTACT